132 related articles for article (PubMed ID: 9398912)
1. Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets.
Czinn SJ; Bierman JC; Diters RW; Blanchard TG; Leunk RD
Helicobacter; 1996 Mar; 1(1):43-51. PubMed ID: 9398912
[TBL] [Abstract][Full Text] [Related]
2. Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets.
Batchelder M; Fox JG; Hayward A; Yan L; Shames B; Murphy JC; Palley L
Helicobacter; 1996 Mar; 1(1):34-42. PubMed ID: 9398911
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Helicobacter pylori infection: a review of the world literature.
van der Hulst RW; Keller JJ; Rauws EA; Tytgat GN
Helicobacter; 1996 Mar; 1(1):6-19. PubMed ID: 9398908
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Fischbach LA; Correa P; Ramirez H; Realpe JL; Collazos T; Ruiz B; Bravo LE; Bravo JC; Casabon AL; Schmidt BA
Aliment Pharmacol Ther; 2001 Jun; 15(6):831-41. PubMed ID: 11380321
[TBL] [Abstract][Full Text] [Related]
6. The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Wagner S; Varrentrapp M; Haruma K; Lange P; Müller MJ; Schorn T; Soudah B; Bär W; Gebel M
Z Gastroenterol; 1991 Nov; 29(11):595-8. PubMed ID: 1771934
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the eradication of Helicobacter pylori with triple therapy.
Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
[TBL] [Abstract][Full Text] [Related]
8. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
9. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
[TBL] [Abstract][Full Text] [Related]
11. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
12. Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Graham DY; Lew GM; Ramirez FC; Genta RM; Klein PD; Malaty HM
Aliment Pharmacol Ther; 1993 Feb; 7(1):111-3. PubMed ID: 8439632
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets.
Marini RP; Fox JG; Taylor NS; Yan L; McColm AA; Williamson R
Am J Vet Res; 1999 Oct; 60(10):1280-6. PubMed ID: 10791942
[TBL] [Abstract][Full Text] [Related]
14. Gastric colonization of the ferret with Helicobacter species: natural and experimental infections.
Fox JG; Otto G; Murphy JC; Taylor NS; Lee A
Rev Infect Dis; 1991; 13 Suppl 8():S671-80. PubMed ID: 1833810
[TBL] [Abstract][Full Text] [Related]
15. Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Alder JD; Ewing PJ; Mitten MJ; Oleksijew A; Tanaka SK
Am J Gastroenterol; 1996 Nov; 91(11):2347-54. PubMed ID: 8931416
[TBL] [Abstract][Full Text] [Related]
16. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
[No Abstract] [Full Text] [Related]
17. Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Dubois A; Berg DE; Fiala N; Heman-Ackah LM; Perez-Perez GI; Blaser MJ
J Gastroenterol; 1998 Feb; 33(1):18-22. PubMed ID: 9497216
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization confirms clearance of visible Helicobacter spp. associated with gastritis in dogs and cats.
Jergens AE; Pressel M; Crandell J; Morrison JA; Sorden SD; Haynes J; Craven M; Baumgart M; Simpson KW
J Vet Intern Med; 2009; 23(1):16-23. PubMed ID: 19175715
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection.
Miehlke S; Bayerdörffer E; Lehn N; Mannes GA; Höchter W; Weingart J; Sommer A; Heldwein W; Müller-Lissner S; Bästlein E
Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):975-8. PubMed ID: 8590144
[TBL] [Abstract][Full Text] [Related]
20. One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Scheiman JM; Chey WD; Behler EM; Crause I; Elta GH
J Clin Gastroenterol; 1996 Oct; 23(3):170-3. PubMed ID: 8899495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
